Scholars Central

Conference abstractPublished 2018

The quest to understand Alzheimers disease and find new treatments

Authors: Anthony Tsarbopoulos

National and Kapodistrian University of Athens Medical School, Greece The Goulandris Natural History Museum, Greece

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s Disease are persistent progressive diseases and they are associated with abnormal accumulation and aggregation of disease-specific proteins and peptides and inclusion bodies in selected brain regions. AD is the most common type of dementia, associated with a decline in cognitive ability and premature death. AD has been puzzling the scientific community for decades, and it has been a major public health problem for which there is currently no disease-modifying treatment. This is mainly caused by the non- definitive hypothesis of the root cause of this disease. It has been proposed that the beta amyloid peptide (Aβ), abnormal tau protein or probably both play critical role in the AD development leading to the formation of senile plaques and neurofibrillary tangles, thus making them promising targets for next-generation drug therapies. To date, there has been a growing knowledge of the underlying cause of AD and multiple active clinical trials for potential treatments. In this presentation, recent progress in the understanding of the AD pathogenesis will be discussed, with emphasis on the amyloid cascade hypothesis, the aggregation mechanism and how to inhibit the formation of Aβ oligomers, because they are considered to be most toxic amyloid species. Our approach combines in vitro screening followed by in vivo evaluation of several bioactive antioxidants as novel aggregation inhibitors. The use of these dietary antioxidants could be a promising way to prevent amyloid toxicity, thus slowing disease progression or even successfully preventing the disease from advancing to dementia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in International Journal of Mental Health & Psychiatry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Mental Health & Psychiatry
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Anthony Tsarbopoulos”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels